Physician profile
Michael D Lee
NPI 1316946619
$42,412.50
in general payments reported to CMS, 2019-2025
10 companies · $9,665 in 2025
The $9,665 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,183 · 2020: $5,412 · 2021: $8,339 · 2022: $9,175 · 2023: $150 · 2024: $490 · 2025: $9,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,613 · Travel and Lodging: $1,541 · Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,612.50 |
| Travel and Lodging | $1,540.71 |
| Food and Beverage | $1,151.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $26,963.36 | 2019-2025 | Velys, Attune |
| Depuy Synthes Products, INC. | $13,851.02 | 2019-2022 | |
| Depuy Synthes Sales INC. | $437.66 | 2020-2024 | Inhance, Attune |
| Stryker Corporation | $425.34 | 2021-2025 | Mako, Iconix |
| Zimmer Biomet Holdings, INC. | $415.75 | 2020-2024 | Tapestry, Rosa, Persona |
| Pacira Therapeutics, INC. | $138.11 | 2019 | |
| Think Surgical, INC. | $126.55 | 2025 | |
| Medshape, INC. | $40.51 | 2023 | |
| Smith+Nephew, INC. | $14.20 | 2025 | Bone Anchors With Arthroscopic Delivery System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$394,460.99 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.